Perifosine + Sunitinib Malate for Patients With Advanced Cancers

NCT00399152 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

15

Enrollment

INDUSTRY

Sponsor class

Conditions

Renal Cancer
GIST

Interventions

DRUG: Perifosine
DRUG: Sunitinib Malate

Sponsor

AEterna Zentaris